$RBRK

Nithrakashyap Arvind sold $6.2M of RBRK

Nithrakashyap Arvind (Chief Technology Officer) sold 72,687 shares of Rubrik, Inc. (RBRK) at $84.75 ($6.16M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Nithrakashyap Arvind
Published Jun 4, 2026, 1:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RBRK
Neutral
medium confidence
Mentioned
$RBRK
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RBRKNeutralLow
01

Why it matters

The disclosure provides a concrete ownership-change datapoint but does not, by itself, indicate a new business development. The 10b5-1 qualifier generally dampens interpretive value for near-term trading.

02

Market read

A routine insider sale disclosure for RBRK; likely more relevant for sentiment/positioning than for fundamental repricing.

03

What to watch

Traders may over-weight insider selling; without changes to guidance, contracts, or litigation, the signal is typically weak.

Relevance 6/10Novelty 6/10Timing: Filed June 3; sale executed June 1 (post-trade disclosure window).

Background

This is an SEC Form 4 insider transaction disclosure for Rubrik, Inc. (officer/director) showing an open-market sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$RBRKNeutralMedium confidence
Context

Rubrik CTO Nithrakashyap Arvind sold $6.16M of RBRK stock via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction may be muted due to 10b5-1 context.

Evidence & confidence

The filing is a routine Form 4 datapoint (sale size and date provided), with no accompanying fundamental catalyst or guidance change in the article.

Market effects

Could slightly affect sentiment around enterprise data security/backup names, but this is company-specific and not a sector catalyst.

Minimal; disclosure pertains to US-listed Rubrik only.

Low; no cross-border deal/regulatory development mentioned.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations; price may ignore it.

Key entities

  • Rubrik, Inc.

    Subject of the insider sale disclosure; CTO sold 72,687 shares for ~$6.16M.

  • Nithrakashyap Arvind

    Rubrik CTO and officer/director who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RBRKMed

Here's How Rubrik Stock Gained 28.6% Last Month

Rubrik (RBRK) rose 28.6% in August 2026, driven by a cybersecurity rally and strong earnings. Q2 2027 earnings showed a profit of $0.20 per share and 41% revenue growth. The stock trades at 12.7x sales and 68x free cash flow, with analysts calling the post-earnings drop a buying opportunity. The company's growth and market position make it appealing despite its high valuation and volatility.

$RBRKMed

Jim Cramer on Rubrik (RBRK): “It Just Came in Maybe Too Hot”

Rubrik, Inc. (RBRK) reported Q2 fiscal 2027 revenue of $427.3M, up 38% YoY, beating estimates. EPS was $0.20, above consensus. Subscription ARR rose 33% to $1.66B. Guidance was raised. Despite strong results, shares dropped 13% post-earnings, possibly due to high expectations. Free cash flow grew 14% YoY, but margins declined. Hedge fund holdings decreased slightly, and short interest is around 9%.

$RBRKMed

Rubrik’s AI Security Bet Could Power the Next Leg Higher

Rubrik reported Q2 earnings with adjusted EPS of $0.20, beating estimates by $0.16. Revenue and earnings guidance exceeded expectations. Analysts raised price targets, with a consensus near pre-release highs. Institutional investors have been accumulating shares. Risks include high valuation and competition, notably from Microsoft. The company expects GAAP profitability by 2028.